Showing results (71-80 of 523) with videos related to

Sort By:
Pageof 53
Blood Pressure. Supplement|January 1, 1994
Isradipine decreases the entry of radioiodine-labelled low-density lipoproteins into the arterial wallC Pirich, P Fitscha, P Schmid, et al.
Prostaglandins, Leukotrienes, and Medicine|August 1, 1984
Plasma factor and platelet sensitivity to prostacyclin in patients with peripheral vascular disease before and after treatment with a combination of a cyclooxygenase and a phosphodiesterase inhibitorE Strobl-Jäger, J Kaliman, H Sinzinger
Prostaglandins, Leukotrienes, and Medicine|September 1, 1986
Prostacyclin synthesis stimulating plasma factor in coronary heart diseaseH Sinzinger, J Kaliman, B A Peskar
European Journal of Nuclear Medicine|January 1, 1986
Imaging of human atherosclerotic lesions using 123I-low-density lipoproteinH Sinzinger, H Bergmann, J Kaliman, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 1, 1989
Effects of taprostene, a chemically stable prostacyclin analogue, in patients with ischaemic peripheral vascular disease: a placebo controlled double-blind trialI Virgolini, P Fitscha, J O'Grady, et al.
Prostaglandins|June 1, 1990
Successful therapy of the prostaglandin defect "Wien-Hietzing" (lack of platelet high-affinity binding sites for prostaglandin I2)G Steurer, J Kaliman, D Gludovacz, et al.
Wiener Klinische Wochenschrift|March 29, 1985
[Defects in the prostaglandin system. II. Familial platelet-prostacyclin receptor defect (Wien-Hietzing defect)--pathogenetic significance for (early) development of atherosclerosis?]J Kaliman, H Sinzinger, M Staudacher, et al.
Wiener Klinische Wochenschrift|April 14, 1989
[Effects of omega-3-fatty acids on the prostaglandin system in healthy probands]A Gazsó, J Kaliman, D F Horrobin, et al.
Prostaglandins|August 1, 1996
Prostaglandin I2-mediated upregulation of 125I-LDL-receptor binding by isradipine in normo- and hypercholesterolemic rabbits in vivoH Sinzinger, G Lupattelli, H Kritz, et al.
Platelets|November 4, 2010
Influence of a single dose of calcium channel blockers on platelet functionK Weiss, P Fitscha, I Virgolini, et al.
Pageof 53